Gilead Rises To Highest Price on Potential Drug Sales

Gilead Sciences Inc. rose to its highest price ever on optimism over potential sales for the company’s experimental hepatitis C medications.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.